Bulgarian Sopharma Trading finalizes acquisition of Serbian Lekovit

The largest Bulgarian pharmaceutical company, Sopharma Trading, took over a 100% stake in the Serbian Lekovit, the Bulgarian company announced today.

The acquisition was carried out through the purchase of minority shares portfolio of Dr. Dragan Petrovic in Lekovit d.o.o, the company says in its press release.

Looking for scale and continuous dynamic growth, the company started regional expansion by entering Serbian market in May 2015 with initial plans aiming at market penetration of exclusive brands portfolio, followed in the summer of 2017 by the acquisition of the majority stakes in the fastest growing Serbian pharma distributor – Lekovit.

Let us remind that Sopharma Trading bought a 70% stake in Lekovit in Serbia on Friday, August 4, 2017, becoming its majority owner.

As Lekovit said, the agreement was signed following the unconditional approval of the agreement on the purchase of a majority stake by the Commission for Protection of Competition of Serbia in late July.

Lekovit was founded in 1992 together with the FLOS retail pharmacy chain. In 2016, it had 150 employees and an operating income of over EUR 50 million.

Sopharma Trading JSC

Sopharma Trading Pharmaceuticals d.o.o. Beograd

Komisija za zaštitu konkurencije Srbije

Sopharma Trading Bulgaria

Sopharma Group

Lekovit Sabac

Sopharma

Commission for Protection of Competition of Serbia

Dragan Petrović